These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31870649)

  • 21. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
    Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
    Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
    Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Kundu B; Dvorácskó S; Basu A; Pommerolle L; Kim KA; Wood CM; Gibbs E; Behee M; Tarasova NI; Cinar R; Iyer MR
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Newman JW; Wheelock CE; Dowdy DL; Hammock BD
    Biochem Pharmacol; 2002 May; 63(9):1599-608. PubMed ID: 12007563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
    Pecic S; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD; Zhu Z; Rinderspacher A; Deng SX
    Bioorg Med Chem Lett; 2013 Jan; 23(2):417-21. PubMed ID: 23237835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of potent non-urea inhibitors of soluble epoxide hydrolase.
    Xie Y; Liu Y; Gong G; Smith DH; Yan F; Rinderspacher A; Feng Y; Zhu Z; Li X; Deng SX; Branden L; Vidović D; Chung C; Schürer S; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2354-9. PubMed ID: 19303288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
    Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
    Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the Design to the
    Codony S; Calvó-Tusell C; Valverde E; Osuna S; Morisseau C; Loza MI; Brea J; Pérez C; Rodríguez-Franco MI; Pizarro-Delgado J; Corpas R; Griñán-Ferré C; Pallàs M; Sanfeliu C; Vázquez-Carrera M; Hammock BD; Feixas F; Vázquez S
    J Med Chem; 2021 May; 64(9):5429-5446. PubMed ID: 33945278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.
    Huang SX; Li HY; Liu JY; Morisseau C; Hammock BD; Long YQ
    J Med Chem; 2010 Dec; 53(23):8376-86. PubMed ID: 21070033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
    Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
    Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
    Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach.
    Jo AR; Kim JH; Yan XT; Yang SY; Kim YH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
    Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
    Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of
    Kim JH; Park JS; Lee YJ; Choi S; Kim YH; Yang SY
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1049-1055. PubMed ID: 34000951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
    Kim IH; Morisseau C; Watanabe T; Hammock BD
    J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.